These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10613669)
21. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. de Moerloose P; Reber G; Perrier A; Perneger T; Bounameaux H Br J Haematol; 2000 Jul; 110(1):125-9. PubMed ID: 10930988 [TBL] [Abstract][Full Text] [Related]
22. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D; Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453 [TBL] [Abstract][Full Text] [Related]
24. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population. Adamczuk Y; Iglesias Varela ML; Forastiero R; Martinuzzo M; Cerrato G; Pombo G; Carreras LO Thromb Haemost; 2000 Mar; 83(3):509-10. PubMed ID: 10744162 [No Abstract] [Full Text] [Related]
25. Incidence of Factor V Leiden and prothrombin G20210A in patients submitted to stem cell transplantation. Chiusolo P; Sica S; De Stefano V; Casorelli I; Laurenti L; Leone G Haematologica; 2000 Jun; 85(6):670-1. PubMed ID: 10870132 [No Abstract] [Full Text] [Related]
27. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma. Pihusch R; Danzl G; Scholz M; Harich D; Pihusch M; Lohse P; Hiller E Cancer; 2002 Jun; 94(12):3120-6. PubMed ID: 12115343 [TBL] [Abstract][Full Text] [Related]
28. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617 [TBL] [Abstract][Full Text] [Related]
29. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601 [TBL] [Abstract][Full Text] [Related]
30. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee. Björkman A; Burtscher IM; Svensson PJ; Hillarp A; Besjakov J; Benoni G Arch Orthop Trauma Surg; 2005 Feb; 125(1):51-5. PubMed ID: 15723247 [TBL] [Abstract][Full Text] [Related]
31. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study. Chaireti R; Jennersjö C; Lindahl TL Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683 [TBL] [Abstract][Full Text] [Related]
32. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia. Fawaz NA; Bashawery L; Al-Sheikh I; Qatari A; Al-Othman SS; Almawi WY Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376 [TBL] [Abstract][Full Text] [Related]
33. The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies. Sucker C; Kurschat C; Hetzel GR; Grabensee B; Maruhn-Debowski B; Loncar R; Ostojic L; Scharf RE; Zotz RB Clin Appl Thromb Hemost; 2009; 15(3):360-3. PubMed ID: 19448164 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960 [TBL] [Abstract][Full Text] [Related]
35. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893 [TBL] [Abstract][Full Text] [Related]
36. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant. Arnutti P; Nathalang O; Cowawintaweewat S; Prayoonwiwat W; Choovichian P Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):869-71. PubMed ID: 12757241 [TBL] [Abstract][Full Text] [Related]
37. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749 [TBL] [Abstract][Full Text] [Related]
38. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978 [TBL] [Abstract][Full Text] [Related]
39. Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature. Dentali F; Ageno W; Bozzato S; Malato A; Gianni M; Squizzato A; Prisco D J Thromb Haemost; 2012 Apr; 10(4):732-7. PubMed ID: 22329698 [No Abstract] [Full Text] [Related]
40. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey. Kabukcu S; Keskin N; Keskin A; Atalay E Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]